TD Cowen Reaffirms Hold Rating for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL)‘s stock had its “hold” rating restated by equities research analysts at TD Cowen in a note issued to investors on Tuesday, Marketbeat reports. They currently have a $85.00 price objective on the stock. TD Cowen’s target price would suggest a potential downside of 0.51% from the stock’s previous close.

CL has been the subject of a number of other research reports. Citigroup upped their price objective on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Bank of America lifted their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Wall Street Zen cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Sunday. Rothschild & Co Redburn set a $93.00 price objective on Colgate-Palmolive in a research report on Friday, February 13th. Finally, Argus reissued a “hold” rating on shares of Colgate-Palmolive in a report on Thursday, December 11th. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $95.19.

Colgate-Palmolive Trading Up 0.2%

Shares of NYSE:CL opened at $85.43 on Tuesday. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. The stock’s 50-day moving average is $91.14 and its 200-day moving average is $83.41. The company has a market cap of $68.54 billion, a P/E ratio of 32.61, a P/E/G ratio of 3.92 and a beta of 0.34. Colgate-Palmolive has a 52-week low of $74.54 and a 52-week high of $99.33.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. The business had revenue of $5.23 billion for the quarter, compared to analyst estimates of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. Colgate-Palmolive’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.91 earnings per share. Equities research analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Insider Buying and Selling at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 97,843 shares of the stock in a transaction dated Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the transaction, the chief financial officer owned 55,310 shares of the company’s stock, valued at $5,214,073.70. This represents a 63.89% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the transaction, the insider owned 13,751 shares of the company’s stock, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders sold 184,683 shares of company stock worth $17,486,693. Insiders own 0.34% of the company’s stock.

Institutional Trading of Colgate-Palmolive

Several institutional investors have recently bought and sold shares of CL. Vanguard Group Inc. grew its position in Colgate-Palmolive by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock valued at $6,633,570,000 after acquiring an additional 1,026,985 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Colgate-Palmolive by 1.4% during the fourth quarter. Geode Capital Management LLC now owns 22,103,901 shares of the company’s stock valued at $1,754,657,000 after acquiring an additional 304,426 shares during the period. Morgan Stanley lifted its holdings in shares of Colgate-Palmolive by 1.7% during the fourth quarter. Morgan Stanley now owns 19,246,217 shares of the company’s stock valued at $1,520,836,000 after acquiring an additional 323,367 shares during the period. Norges Bank acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $861,670,000. Finally, Deutsche Bank AG grew its holdings in shares of Colgate-Palmolive by 33.9% in the 4th quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock worth $857,040,000 after purchasing an additional 2,746,920 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.